Shantell Laketa Heiber

Array ( [id] => 4379008 [patent_doc_number] => 06261765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs)' [patent_app_type] => 1 [patent_app_number] => 9/379605 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 18382 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261765.pdf [firstpage_image] =>[orig_patent_app_number] => 379605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1344331 [patent_doc_number] => 06579526 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes' [patent_app_type] => B1 [patent_app_number] => 09/374766 [patent_app_country] => US [patent_app_date] => 1999-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 50 [patent_no_of_words] => 29993 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579526.pdf [firstpage_image] =>[orig_patent_app_number] => 09374766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650753 [patent_doc_number] => 07112330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-26 [patent_title] => 'Method for producing yeast expressed HPV types 6 and 16 capsid proteins' [patent_app_type] => utility [patent_app_number] => 09/762762 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 9507 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112330.pdf [firstpage_image] =>[orig_patent_app_number] => 09762762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520059 [patent_doc_number] => 06413522 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them' [patent_app_type] => B1 [patent_app_number] => 09/319056 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9331 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413522.pdf [firstpage_image] =>[orig_patent_app_number] => 09319056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493360 [patent_doc_number] => 06342229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-01-29 [patent_title] => 'Herpesvirus particles comprising fusion protein and their preparation and use' [patent_app_type] => B2 [patent_app_number] => 09/366286 [patent_app_country] => US [patent_app_date] => 1999-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4167 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342229.pdf [firstpage_image] =>[orig_patent_app_number] => 09366286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 706858 [patent_doc_number] => 07060282 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Attenuated equine herpesvirus' [patent_app_type] => utility [patent_app_number] => 09/744799 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5637 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060282.pdf [firstpage_image] =>[orig_patent_app_number] => 09744799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372611 [patent_doc_number] => 06303128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Method for protein expression' [patent_app_type] => 1 [patent_app_number] => 9/358645 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4466 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303128.pdf [firstpage_image] =>[orig_patent_app_number] => 358645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261825 [patent_doc_number] => 06306397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Variants of human papilloma virus antigens' [patent_app_type] => 1 [patent_app_number] => 9/359382 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 11822 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306397.pdf [firstpage_image] =>[orig_patent_app_number] => 359382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523472 [patent_doc_number] => 06352832 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => B1 [patent_app_number] => 09/359193 [patent_app_country] => US [patent_app_date] => 1999-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 40 [patent_no_of_words] => 18235 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352832.pdf [firstpage_image] =>[orig_patent_app_number] => 09359193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082699 [patent_doc_number] => 06162608 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Nuclear matrix protein fluid assay' [patent_app_type] => 1 [patent_app_number] => 9/357898 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 9447 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162608.pdf [firstpage_image] =>[orig_patent_app_number] => 357898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4341741 [patent_doc_number] => 06284455 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Diagnosis of penaeus monodon-type baculovirus by PCR' [patent_app_type] => 1 [patent_app_number] => 9/352996 [patent_app_country] => US [patent_app_date] => 1999-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 6119 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284455.pdf [firstpage_image] =>[orig_patent_app_number] => 352996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4310277 [patent_doc_number] => 06242176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Papillomavirus cellular receptor' [patent_app_type] => 1 [patent_app_number] => 9/348573 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3741 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242176.pdf [firstpage_image] =>[orig_patent_app_number] => 348573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4148533 [patent_doc_number] => 06123948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation' [patent_app_type] => 1 [patent_app_number] => 9/347483 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 3 [patent_no_of_words] => 14284 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/123/06123948.pdf [firstpage_image] =>[orig_patent_app_number] => 347483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4363080 [patent_doc_number] => 06287571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Replication-defective adenovirus human type 5 recombinant as a vaccine carrier' [patent_app_type] => 1 [patent_app_number] => 9/347060 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 24 [patent_no_of_words] => 11999 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287571.pdf [firstpage_image] =>[orig_patent_app_number] => 347060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548554 [patent_doc_number] => 06399075 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Compositions and methods for treating Papillomavirus-infected cells' [patent_app_type] => B1 [patent_app_number] => 09/347504 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 29875 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399075.pdf [firstpage_image] =>[orig_patent_app_number] => 09347504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1573848 [patent_doc_number] => 06468538 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis' [patent_app_type] => B1 [patent_app_number] => 09/331924 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7232 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468538.pdf [firstpage_image] =>[orig_patent_app_number] => 09331924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152236 [patent_doc_number] => 06107086 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions' [patent_app_type] => 1 [patent_app_number] => 9/330076 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4854 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107086.pdf [firstpage_image] =>[orig_patent_app_number] => 330076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602500 [patent_doc_number] => 06432679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220' [patent_app_type] => B1 [patent_app_number] => 09/328599 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432679.pdf [firstpage_image] =>[orig_patent_app_number] => 09328599 [rel_patent_id] =>[rel_patent_doc_number] =>)